Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis

Atherosclerosis

Volumn 135, Issue 2, 1997, Pages 145-159

  Fisher, Rachel M ^a   Humphries, Steve E ^a   Talmud, Philippa J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Body mass index; Genetic variation; Triacylglycerol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; BODY MASS; DRUG EFFECT; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME RELEASE; GENETIC PREDISPOSITION; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

ARTERIOSCLEROSIS; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; RISK FACTORS; VARIATION (GENETICS);

EID: 0031470430     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00199-8     Document Type: Review

References (87)

1. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicromemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1989:1165.
2. Huttunen J.K., Ehnholm C., Kekki M., Nikkila E.A. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med. 50:1976;249.
3. Pollare T., Vessby B., Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 11:1991;1192.
4. Taskinen M-R. Lipoprotein lipase in hypertriglyceridemias. In: Borensztajn J, editor. Lipoprotein lipase. Chicago: Evener Publishers, 1987:201.
5. Beaudet A.L., Tsui L.-C. A suggested nomenclature for designating mutations. Hum Mutat. 2:1993;245.
6. Olivecrona T., Bengtsson G., Osborne J.C. Molecular properties of lipoprotein lipase. Effects of limited trypsin digestion on molecular weight and secondary structue. Eur J Biochem. 124:1982;629.
7. Winkler F.K., D'Arcy A., Hunziker W. Structure of human pancreatic lipase. Nature. 343:1990;771.
8. Faustinella F., Smith L.C., Semenkovich C.F., Chan L. Structural and functional roles of highly conserved serines in human lipoprotein lipase. Evidence that serine 132 is essential for enzyme catalysis. J Biol Chem. 266:1991;9481.
9. Wang C.S., Hartsuck J., McConathy W.J. Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta. 1123:1992;1.
10. Yang C.Y., Gu Z.W., Yang H.X., Rohde M.F., Gotto A.M. Jr., Pownall H.J. Structure of bovine milk lipoprotein lipase. J Biol Chem. 264:1989;16822.
11. Enerback S., Semb H., Bengtsson Olivecrona G., Carlsson P., Hermansson M.L., Olivecrona T., Bjursell G. Molecular cloning and sequence analysis of cDNA encoding lipoprotein lipase of guinea pig. Gene. 58:1987;1.
12. Santamarina-Fojo S. Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotien C-II. Curr Opin Lipidol. 3:1992;186.
13. Santamarina-Fojo S., Brewer H.B. Jr. The familial hyperchylomicronemia syndrome - new insights in to underlying genetic defects. J Am Med Assoc. 265:1991;904.
14. Ma Y., Henderson H.E., Murphy M.R.V., Roederer G., Monslave M.V., Clarke L.A., Normand T., Julien P., Gagné C., Lambert M., Davignon J., Lupien P.J., Brunzell J.D., Hayden M.R. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. New Engl J Med. 324:1991;1761.
15. Mailly F, Palmen J, Talmud PJ, Muller DPR, Gibbs T, Lloyd J, Brunzell JD, Durrington P, Mitropoulos KA, Betteridge DJ, Watts G, Lithell H, Angelico F, Humphries SE. Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in twenty patients from the UK, Sweden and Italy. Hum Mutat 1997 (in press).
16. Stalenhof A.F.H., Armstrong V.W., Steinmetz A., Taskinen M.-R., Zechner R. The 17th annual meeting of the European Lipoprotein Club. Arterioscler Thromb Vasc Biol. 15:1995;543.
17. Hata A., Ridinger D.N., Sutherland S.D., Emi M., Kwong L.K., Shuhua J., Lubbers A., Guy Grand B., Basdevant A., Iverius P.H.et al. Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization. J Biol Chem. 267:1992;20132.
18. Babirak S.P., Brown B.G., Brunzell J.D. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb. 12:1992;1176.
19. Kwiterovich P.O. Jr. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol. 4:1993;133.
20. Sniderman A., Shapiro S., Marpole D., Malcolm I., Skinner B., Kwiterovich P.O. Jr. The association of coronary atherosclerosis and hyperlipoproteinemia (increased protein but normal cholesterol content in human plasma low density lipoprotein). Proc Natl Acad Sci USA. 97:1980;604.
21. Venkatesan S., Cullen P., Pacy P., Halliday D., Scott J. Stable isotopes show a direct relation between VLDL apo B overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb. 13:1993;1110.
22. Austin M.A., Brunzell J.D., Fitch W.L., Krauss R.M. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 10:1990;520.
23. de Graaf J., Hak Lemmers H.L., Hectors M.P., Demacker P.N., Hendriks J.C., Stalenhoef A.F. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 11:1991;298.
24. Seed M., Mailly F., Vallance D., Doherty E., Winder A., Talmud P., Humphries S.E. Lipoprotein lipase activity in patients with combined hyperlipidemia. Clin Invest. 72:1994;100.
25. Sparkes R.S., Zollman S., Klisak I., Kirchgessner T.G., Komaromy M.C., Mohandas T., Schotz M.C., Lusis A.J. Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics. 1:1987;138.
26. Deeb S.S., Peng R. Structure of the human lipoprotein lipase gene. Biochemistry. 28:1989;4131.
27. Fisher K.I., FitzGerald G.A., Lawn R.M. Two polymorphisms in the human lipoprotein lipase (LPL) gene. Nucleic Acids Res. 15:1987;7657.
28. Heinzmann C., Ladias J., Antonarakis S., Kirchgessner T., Schotz M., Lusis A.J. RFLP for the human lipoprotein lipase (LPL) gene: HindIII. Nucleic Acids Res. 15:1987;6763.
29. Li S., Oka K., Galton D., Stocks J. Bst-1 RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res. 16:1988;11856.
30. Hegele R.A., Nakamura Y., Emi M., Lalouel J.M., White R. A BglII RFLP at the lipoprotein lipase gene. Nucleic Acids Res. 17:1989;8899.
31. Hegele R.A., Nakamura Y., Emi M., Lalouel J.M., White R. Two RFLPs at the lipoprotein lipase (LPL) gene. Nucleic Acids Res. 17:1989;10146.
32. Funke H., Reckwerth A., Stapenhorst D., Schulze Beiering M., Jansen M., Assmann G. Bst NI (Eco RII) RFLP in the lipoprotein lipase gene (LPL). Nucleic Acids Res. 16:1988;2741.
33. Peacock R.E., Hamsten A., Nilsson-Ehle P., Humphries S.E. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 97:1992;171.
34. Jemaa R., Fumeron F., Poirier O., Lecerf L., Evans A., Arveiler D., Luc G., Cambou J.-P., Bard J.-M., Fruchart J.-C., Apfelbaum M., Cambien F., Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res. 36:1995;2141.
35. Chamberlain J.C., Thorn J.A., Oka K., Galton D.J., Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 79:1989;85.
36. Heizmann C., Kirchgessner T., Kwiterovich P.O., Ladias J.A., Derby C., Antonarakis S.E., Lusis A.J. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet. 86:1991;578.
37. Ahn Y.I., Kamboh M.I., Hamman R.F., Cole S.A., Ferrell R.E. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 34:1993;421.
38. Cole S.A., Aston C.E., Hamman R.F., Ferrell R.E. Association of a PvuII RFLP at the lipoprotein lipase locus with fasting insulin levels in Hispanic men. Genet Epidemiol. 10:1993;177.
39. Enerbäck S., Ohlsson B.G., Samuelsson L., Bjursell G. Characterisation of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-α and LP-β, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Mol Cell Biol. 12:1992;4622.
40. Mailly F., Tugrul Y., Reymer P.W.A., Bruin T., Seed M., Groenemeyer B.F., Asplund-Carlson A., Vallance D., Winder A.F., Miller G.J., Kastelein J.J.P., Hamsten A., Olivecrona G., Humphries S.E., Talmud P. A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol. 15:1995;468.
41. Fisher R.M., Mailly F., Peacock R.E., Hamsten A., Seed M., Yudkin J.S., Beisiegel U., Feussner G., Miller G., Humphries S.E., Talmud P.J. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidaemic subjects, myocardial infarction survivors and healthy adults. J Lipid Res. 36:1995;2104.
42. Hata A., Robertson M., Emi M., Lalouel J.-M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 18:1990;5407.
43. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, Faergerman O, on behalf of the EARS Group. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations. Studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 1997;96:733.
44. Reymer P.W.A., Groenemeyer B.E., Gagné E., Miao L., Appelman E.E.G., Seidel J.C., Kromhout D., Bijvoet S.M., van de Oever K., Bruin T., Hayden M.R., Kastelein J.J.P. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet. 4:1995;1543.
45. Hoffer M.J.V., Bredie S.J.H., Boomsma D.I., Reymer P.W.A., Kastelein J.J.P., de Knijff P., Demacker P.N.M., Stalenhof A.F.H., Havekes L.M., Frants R.R. The lipoprotein lipase (Asn291→Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis. 119:1996;159.
46. de Bruin T.W.A., Mailly F., van Barlingen H.H.J.J., Fisher R., Castro Cabezas M., Talmud P., Dallinga-Thie G.M., Humphries S.E. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipideaemia. Eur J Clin Invest. 26:1996;631.
47. Zhang H., Reymer P.W.A., Liu M.-S., Forsythe I.J., Groenemeyer B.E., Frolich J., Brunzell J.D., Kastelein J.J.P., Hayden M.R., Ma Y. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291→Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol. 15:1995;1695.
48. Minnich A., Kessling A., Roy M., Giry C., DeLangavant G., Lavigne J., Lussier-Cacan S., Davignon J. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res. 36:1995;117.
49. Humphries S.E., Lane A., Green F.R., Copper J., Miller G.J. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb. 14:1994;193.
50. Mailly F., Fisher R.M., Nicaud V., Luong L.-A., Evans A.E., Marques-Vidal P., Luc G., Arveiler D., Bard J.M., Poirier O., Talmud P.J., Humphries S.E. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis. 122:1996;21.
51. Zhang Q., Cavanna J., Winkelman B.R., Gross W., Marz W., Galton D.J. Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin Genet. 48:1995;293.
52. 9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 94:1996;1913.
53. Reymer P.W.A., Gagné E., Groenemeyer B.E., Zhang H., Forsyth I., Jansen H., Seidell J.C., Kromhout D., Kastelein J., Hayden M.R. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 10:1995;28.
54. Wittrup H.W., Tybjærg-Hansen A., Abildgaard S., Steffensen R., Schnohr P., Nordestgaard B.G. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischaemic heart disease. J Clin Invest. 99:1997;1606.
55. 291→Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res. 37:1996;727.
56. Ma Y., Ooi T.C., Liu M.-S., Zhang H., McPherson R., Edwards A.L., Forsythe I.J., Frolich J., Brunzell J.D., Hayden M.R. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res. 35:1994;1066.
57. Pimstone S.N., Clee S.M., Gagné E., Miao L., Zhang H., Stein E.A., Hayden M.R. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res. 37:1996;1675.
58. 262→His). J Lipid Res. 37:1996;651.
59. Zhang H., Henderson H., Gagne S.E., Clee S.M., Miao L., Liu G., Hayden M.R. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1302:1996;159.
60. Elbein S.C., Yeager C., Kwong L.K., Lingam A., Inoue I., Lalouel J.-M., Wilson D.E. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J Clin Endocrinol Metab. 79:1994;1450.
61. Ma Y, Zhang H, Liu M-S, Frolich J, Brunzell JD, Hayden MR. Type III hyperlipoproteinemia in apo E2/2 homozygotes: possible role of mutations in the lipoprotein lipase gene. Circulation 1993;88:I-179 (abstract).
62. 291→Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Let. 367:1995;257.
63. Krapp A., Zhang H., Ginizinger D., Liu M.-S., Lindberg A., Olivecrona G., Hayden M.R., Beisiegel U. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells. J Lipid Res. 36:1995;2362.
64. Kobayashi J., Nishida T., Ameis D., Stahnke G., Schotz M.C., Hashimoto H., Fukamachi I., Shirai K., Saito Y., Yoshida S. A heterozygous mutation (the codon for Ser447 - a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun. 182:1992;70.
65. Faustinella F, Chang A, Van Biervliet JP, Rosseneu M, Vinaimont N, Smith LC, Chen SH, Chan L. Catalytic triad residue mutation (Asp156 - Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447 - Ter) in a Turkish family (published erratum appears in J Biol Chem 1992 Apr 5;267(10):7194). J Biol Chem 1991;266:14 418.
66. 410→Val) leads to enzyme inactivation and familial chylomicronemia. J Lipid Res. 35:1994;1552.
67. Nevin D.N., Brunzell J.D., Deeb S.S. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb. 14:1994;869.
68. Stocks J., Thorn J.A., Galton D.J. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res. 33:1992;853.
69. Mattu R.K., Needham E.W.A., Morgan R., Rees A., Hackshaw A., Stocks J., Elwood P.C., Galton D.J. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb. 14:1994;1090.
70. 447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol. 17:1997;595.
71. Kobayashi J., Shirai K., Saito Y., Yoshida S. Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidaemia. Eur J Clin Invest. 19:1989;424.
72. Salinelli S., Lo J.-Y., Mims M.P., Zsigmond E., Smith L.C., Chan L. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center. J Biol Chem. 271:1996;21906.
73. Yang W.-S., Nevin D.N., Peng R., Brunzell J.D., Deeb S.S. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipiemia and low LPL activity. Proc Natl Acad Sci USA. 92:1995;4462.
74. Yang W.-S., Nevin D.N., Peng R., Brunzell J.D., Deeb S.S. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity (Erratum). Proc Natl Acad Sci USA. 93:1996;524.
75. Yang W.-S., Nevin D.N., Iwasaki L., Peng R., Brown B.G., Brunzell J.D., Deeb S.S. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemai and coronary heart disease. J Lipid Res. 37:1996;2627.
76. Hall S, Chu G, Miller G, Cruickshank K, Cooper JA, Humphries SE, Talmud PJ. A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vasc Biol, 1997 (in press).
77. Talmud PJ, Hall S, Chu G, Ginsberg HN, Ramakrishnan R, Miller G, Humphries SE. Lipoprotein lipase -93T/G transition is associated with lower plasma triglyceride levels and increases promoter activity in vitro. Circulation 1996;94:I-273 (abstract).
78. Chaturvedi N., McKeigue P.M., Marmot M.G. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia. 37:1994;765.
79. Fontbonne A., Papoz L., Eschwege E., Roger M., Saint Paul M., Simon D. Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes. 41:1992;1385.
80. Castelli W.P. The triglyceride issue: a view from Framingham. Am Heart J. 112:1986;432.
81. Garrow J. Importance of obesity. Br Med J. 303:1991;704.
82. Miesenbock G., Holzl B., Foger B., Brandstatter E., Paulweber B., Sandhofer F., Patsch J.R. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 91:1993;448.
83. Podl T.R., Zmuda J.M., Yurgalevitch S.M., Fahrenbach M.C., Bausserman L.L., Terry R.B., Thompson P.D. Lipoprotein lipase activity and plasma triglyceride clearance are elevated in endurance-trained women. Metabolism. 43:1994;808.
84. Gagné E., Genest J., Zhang H., Clarke L.A., Hayden M.R. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb. 14:1994;1250.
85. Kozaki K., Gotoda T., Kawamura M., Shimano H., Yazaki Y., Ouchi Y., Yamada N. Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation. J Lipid Res. 34:1993;1765.
86. Funke H., Assmann G. The low down on lipoprotein lipase. Nature Genet. 10:1995;6.
87. Salah D., Bohnet K., Gueguen R., Siest G., Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res. 38:1997;904.